Bioneer : Outcomes of Annual Meeting of Shareholders
March 29, 2022 at 01:34 am
Share
Outcomes of Annual Meeting of Shareholders
1. ApprovalㆍReport of Financial Statements
제 30기
(Mil. KRW)
A. Non-Consolidated Financial Statements
- Total Assets
222,881
- Sales Amount
127,260
- Total Liabilities
41,378
- Operating Income
29,270
- Capital Stock
12,905
- Net Income
14,434
- Total Shareholders' Equity
181,502
*Earnings per Share (KRW)
570
B. Consolidated Financial Statements
- Total Assets
262,418
- Sales Amount
223,744
- Total Liabilities
54,826
- Operating Income
47,064
- Capital Stock
12,905
- Net Income
29,199
- Total Shareholders' Equity
207,592
*Earnings per Share (KRW)
1,073
* External Auditor's Opinion
Non-Consolidated Financial Statements
Unqualified Opinion
Consolidated Financial Statements
Unqualified Opinion
2. DecisionㆍReport on Dividend
A. Cash Dividend and Dividend in Kind
Class of Dividend
-
- Details of Assets
-
Dividend per Share (KRW)
Common Shares
Year-end Dividend
-
InterimㆍQuarterly Dividend
-
Different Classes of Shares
Year-end Dividend
-
InterimㆍQuarterly Dividend
-
Total Dividends(KRW)
-
Dividend Rate to Market Price(%)(Including Interim Dividend)
Common Shares
-
Different Classes of Shares
-
B. Stock Dividend
Stock Dividend Rate(%)
Common Shares
-
Different Classes of Shares
-
Total Stock Dividends
Common Shares
-
Different Classes of Shares
-
3. Appointment of Directors, etc.(As of the Appointment Date)
A. Details of Appointment
Reappointment of an internal director (Jinpyeong Jeong)
B. Number of Outside Directors after Appointment
Total Number of Directors
7
Total Number of Outside Directors
2
Outside Director Appointment Ratio(%)
28.57
C. Number of Auditors after Appointment
Standing Auditor
1
Non-Standing Auditor
-
D. Members of Audit Committee after Appointment
Members of Audit Committee who are Outside Directors
-
Members of Audit Committee who are not Outside Directors
-
4. Details of Other Resolutions
○ Item 1: Approval of consolidated and separate financial statements for the 30th Term
→ Approved as Proposed
○ Item 2: Amendment of Articles of Incorporation
→ Rejected
○ Item 3: Appointment of directors
No.3-1: Reappointment of Jinpyeong Jeong as internal director
→ Approved as Proposed
○ Item 4: Approval of a limit on directors' remuneration
→ Rejected
○ Item 5: Approval of a limit on auditor's remuneration
→ Rejected
5. Date of General Meeting of Shareholde
2022-03-28
6. Other references useful for making investment decisions
-
※Title and date of other disclosure related to this one
2022-03-28 Outcomes of Annual Meeting of Shareholders
2022-03-03 Resolutions for Convocation of General Meeting of Shareholders
2022-02-25 Resolutions for Convocation of General Meeting of Shareholders
Appointment Details of Directors
Name
Date of Birth(Year and month)
Term of Office
Newly Appointed
Curriculum Vitae(Including Present Position)
Jinpyeong Jeong
1963-12
2
Reappointed
- Bachelor of Business Management in Chungbuk National University('89)
- OHSUNG Co., Ltd, Management Planning Dept. / OHSUNG Electronics Co., Ltd, Accounting Dept. ('89- '93)
- SKY Electronics Co., Ltd, Accounting Dept. ('94- '97)
- Bioneer Corporation, Head of Management Support Dept. ('97- Present)
- Future Eng., Auditor ('04- Present)
- RNA Pharm, Auditor ('21- Present)
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bioneer Corporation published this content on 29 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 March 2022 00:33:00 UTC.
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and RNA interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Companyâs products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.